COVID 19: in the eye of the cytokine storm

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

(2020) Marc Feldmann et al.   LANCET

An inflammatory cytokine signature predicts COVID-19 severity and survival

(2020) Diane Marie Del Valle et al.   NATURE MEDICINE

A dynamic COVID-19 immune signature includes associations with poor prognosis

(2020) Adam G. Laing et al.   NATURE MEDICINE

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

(2020) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19

(2020) R. Vinci et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Promises and challenges of targeting inflammation to treat cardiovascular disease: the post-CANTOS era

(2019) Luigi M Biasucci et al.   EUROPEAN HEART JOURNAL